2025 Cancer Updates GI and Breast

Learn How to Claim Your Credit

 

The Cancer Updates Conference will consist of educational activities designed to meet the needs of medical oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of GU and Lung Cancers. Each agenda is comprised of presentations that will break down the most clinically relevant information applicable to community care. This dinner program will be hosted as an in-person event only.

Event Page

 

Accreditation Information | 1.75

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 
  • Amedco LLC designates this activity for a maximum of 1.75 ANCC contact hours.

  • Amedco LLC designates this live activity for a maximum of 1.75 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Amedco LLC designates this activity for a maximum of 1.75 knowledge-based CPE contact hours. JA4008163-9999-25-197-L01-P | JA4008163-9999-25-197-L01-T

    NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prio

  • Total Health Conferences Cancer Updates GI and Breast October 30, 2025 - Boston, MA

    Acknowledgement of Financial Commercial Support

    No financial commercial support was received for this educational activity.

    Acknowledgement of In-Kind Commercial Support

    No in-kind commercial support was received for this educational activity.

    Satisfactory Completion Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

    Joint Accreditation Statement

    In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health Conferences. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Professions in scope for this activity are listed below. Amedco Joint Accreditation Provider Number: 4008163

    Physicians

    Amedco LLC designates this live activity for a maximum of 1.75 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Pharmacists & Pharmacy Technicians

    Amedco LLC designates this activity for a maximum of 1.75 knowledge-based CPE contact hours. JA4008163-9999-25-197-L01-P | JA4008163-9999-25-197-L01-T NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.

    Nurses

    Amedco LLC designates this activity for a maximum of 1.75 ANCC contact hours. Learner Notification

    Objectives - After Attending This Program You Should Be Able To

    1. Review recent clinical advances in the treatment of gastrointestinal (GI) and breast cancers, with a focus on the most relevant data from recent studies and clinical trials.

    2. Evaluate the role of emerging therapies in GI and breast cancer treatment, including new medications, targeted therapies, and immunotherapies.

    3. Apply evidence-based strategies to improve patient outcomes in community oncology settings, focusing on the integration of new treatment approaches.

    Disclosure of Conflict of Interest The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)

    All individuals in a position to control the content of CE are listed below

    Name Commercial Interest:Relationship

    BRUNO BOCKORNY AGENUS:Research Grant Site Principal Investigator

    ENLIVEX, BLUEPRINT MEDICINES:Scientific/Medical Advisory Board Member

    Kristina Fanucci NA

    Brandon Huffman Lilly: Consultant

    Aparna Parikh

    Checkmate Pharma, Natera :Advisory Board Participant

    Roche:Scientific Oversight Committee

    Eli Lilly: Consultant

    Plexxicon, BMS , Novartis , Puretech Pharma , Daiichi Sankyo:Research Grant Site

    Principal Investigator

    PMV Pharma:Research Grant Overall Principal Investigator

    Pfizer :Scientific/Medical Advisory Board Member

    BMS: Other

    Sarah Sammons

    AstraZeneca, Daichi Sankyo, Gilead Sciences, Lilly, Novartis, Pfizer, Relay

    Therapeutics, Seagen: Consultant

    AstraZeneca, Alterome, BioNtech, Daiichi Sankyo, Iambic, Lilly, Lilly, Relay

    Therapeutics:Research Grant Overall Principal Investigator

    Matthew Strickland BMS, Sedwick Claims Management, Bayer, Astellas, SOFIE, PRIME Education,

    Talem Health:Consultant

    Megan Tesch NA

    Adrienne Waks

    Gilead, Genentech, Macrogenics (ended 2024), Merck, TerSera:Other

    AstraZeneca, AMBRX (ended 2024), Johnson and Johnson:Consultant

    AstraZeneca (2/2024), Genentech (5/2025):Speakers Bureau

    Reyna Wilhelm NA

    Justin Kaiser NA

    How to Get Your Certificate

    1. Go to thc.cmecertificateonline.com

    2. Click on the Cancer Updates GI and Breast link.

    3. Evaluate the meeting.

    4. Print, download, or save your certificate for your records.

    5. If you lose your certificate, or need help, go to help.cmecertificateonline.com

 
 

How to Get Your Certificate

  1. Go to thc.cmecertificateonline.com

    Evaluate the meeting.

  2. Print, download, or save your certificate for your records.

  3. If you lose your certificate, or need help, go to help.cmecertificateonline.com

Claim CME
 
Previous
Previous

2025 Northwell Health Second Annual Head and Neck Cancer Symposium

Next
Next

2025 ESMO East